Triclinic Labs

Triclinic Labs is a US-based, FDA-registered contract research organization that is a leader in solid-state development and materials characterization for the pharmaceutical and chemical industries. The company leverages nearly four decades of collective scientific experience to offer services ranging from polymorph and salt screening to cGMP analytical method development and intellectual property litigation support. It differentiates itself through direct client access to lead scientists, flexibility in service levels (both GMP and non-GMP), and a proven track record evidenced by a 98.3% client repeat rate. Triclinic Labs operates as a specialized, high-touch service provider aimed at solving complex solid-state chemistry challenges efficiently and cost-effectively.

Integrated suite of expert services and analytical techniques for solid-state chemical development, materials characterization, and intellectual property support. Core expertise includes polymorph/salt/cocrystal screening, crystallization development, and comprehensive physicochemical analysis using XRPD, DSC, TGA, Raman, FTIR, and microscopy.

Triclinic Labs competes in a specialized segment of the broader CRO market. Competitors range from large, full-service CROs (e.g., LabCorp, Charles River) with analytical divisions to smaller niche labs and academic core facilities. Its differentiation lies in its deep, focused expertise in solid-state chemistry, direct client access to scientists, and integrated IP support services.